Speakers | Kisaco Research

Speakers

The UPC Litigation Forum
20 January, 2025
Amsterdam, Beurs Van Berlage Centre
  • Author:

    Agathe Michel-De-Cazotte

    Partner
    Carpmaels & Ransford

    Agathe Michel-De-Cazotte

    Partner
    Carpmaels & Ransford
  • Author:

    Andreas Robinson

    Senior Counsel Intellectual Property & Litigation
    Amgen

    Andreas Robinson

    Senior Counsel Intellectual Property & Litigation
    Amgen
  • Author:

    Andrew Hutchinson

    Partner
    Simmons & Simmons

    Andrew Hutchinson

    Partner
    Simmons & Simmons
  • Author:

    Antje Brambrink

    Counsel
    Finnegan

    Dr. Antje Brambrink is qualified and admitted as an attorney at law in Germany. She advises and represents clients in complex patent disputes on all IP-related matters, often at the interface of antitrust and regulatory laws. Her expertise covers various fields of technology with a focus on pharmaceuticals, biotechnology, med-tech, as well as renewable energies and high-tech. Our clients appreciate Antje’s deep understanding of the life sciences sector based on her dual qualification as a licensed dentist.

     

    As a patent litigator, Antje represents clients in infringement, preliminary injunction and inspection proceedings before German district and appeal courts as well as in nullity and compulsory license proceedings at the German Federal Patent Court and the Federal Supreme Court.

     

    In addition to her work as a litigator, Antje advises clients strategically on all issues relating to intellectual property rights (patents, utility models, supplementary protection certificates), such as contracts for the licensing and transfer of rights also in connection with international transactions or the newly established Unified Patent Court (UPC). She has extensive experience in the European coordination of multinational patent disputes.

     

    Prior to joining Finnegan, Antje practiced patent litigation for several years in the patent litigation teams of two international law firms seated in Germany. Antje’s medical and scientific background is of great benefit in advising clients from the life sciences sector. Renowned pharmaceutical, biotechnology and medical devices companies regularly seek her advice. She also advises in the field of renewable energies and in the enforcement of standard-essential patents.

    Antje Brambrink

    Counsel
    Finnegan

    Dr. Antje Brambrink is qualified and admitted as an attorney at law in Germany. She advises and represents clients in complex patent disputes on all IP-related matters, often at the interface of antitrust and regulatory laws. Her expertise covers various fields of technology with a focus on pharmaceuticals, biotechnology, med-tech, as well as renewable energies and high-tech. Our clients appreciate Antje’s deep understanding of the life sciences sector based on her dual qualification as a licensed dentist.

     

    As a patent litigator, Antje represents clients in infringement, preliminary injunction and inspection proceedings before German district and appeal courts as well as in nullity and compulsory license proceedings at the German Federal Patent Court and the Federal Supreme Court.

     

    In addition to her work as a litigator, Antje advises clients strategically on all issues relating to intellectual property rights (patents, utility models, supplementary protection certificates), such as contracts for the licensing and transfer of rights also in connection with international transactions or the newly established Unified Patent Court (UPC). She has extensive experience in the European coordination of multinational patent disputes.

     

    Prior to joining Finnegan, Antje practiced patent litigation for several years in the patent litigation teams of two international law firms seated in Germany. Antje’s medical and scientific background is of great benefit in advising clients from the life sciences sector. Renowned pharmaceutical, biotechnology and medical devices companies regularly seek her advice. She also advises in the field of renewable energies and in the enforcement of standard-essential patents.

  • Author:

    Aoife Murphy

    Partner
    DLA Piper

    Aoife Murphy

    Partner
    DLA Piper
  • Author:

    Arjan Reijns

    Legal Director Amsterdam
    Pinsent Masons

    Arjan Reijns

    Legal Director Amsterdam
    Pinsent Masons
  • Author:

    Arvid van Oorschot

    Partner
    Vondst

    Arvid van Oorschot

    Partner
    Vondst
  • Author:

    Benjamin May

    Partner
    Aramis

    Benjamin May was admitted to practice law in 2000 and further admitted to the panel of “Intellectual Property specialists” with the Bar Association. Practice head of IP at Aramis, Benjamin specializes in cross-border patent litigation with a focus on pharmaceuticals, medical devices and biotechs. The 7 attorneys of the IP team are all internationally trained and address a wide range of patent law matters (e.g. invalidity strategies, infringement, launching at risk, preliminary injunctions, licensing, R&D and consortium agreements). In 2023 the team was ranked amongst the leading patent litigation practices in France, and Benjamin as “leading individual” (Legal 500).

    Benjamin May

    Partner
    Aramis

    Benjamin May was admitted to practice law in 2000 and further admitted to the panel of “Intellectual Property specialists” with the Bar Association. Practice head of IP at Aramis, Benjamin specializes in cross-border patent litigation with a focus on pharmaceuticals, medical devices and biotechs. The 7 attorneys of the IP team are all internationally trained and address a wide range of patent law matters (e.g. invalidity strategies, infringement, launching at risk, preliminary injunctions, licensing, R&D and consortium agreements). In 2023 the team was ranked amongst the leading patent litigation practices in France, and Benjamin as “leading individual” (Legal 500).

  • Author:

    Brian Goldberg

    Counsel
    Dechert

    Brian M. Goldberg is a Counsel in Dechert LLP’s intellectual property practice with a focus on life sciences patent litigation. Mr. Goldberg has successfully litigated patent cases through bench and jury trials, as well as parallel PTAB proceedings, with vast experience litigating Hatch-Waxman Act ANDA infringement actions. Mr. Goldberg has extensive first-hand experience applying the doctrine of equivalents in patent litigations involving small molecule and biologic pharmaceutical products. Mr. Goldberg’s neuroscience background and deep understanding of the statutory and regulatory framework of the Hatch-Waxman Act provides him invaluable insight in litigating cases to achieve successful outcomes for his clients.

    Brian Goldberg

    Counsel
    Dechert

    Brian M. Goldberg is a Counsel in Dechert LLP’s intellectual property practice with a focus on life sciences patent litigation. Mr. Goldberg has successfully litigated patent cases through bench and jury trials, as well as parallel PTAB proceedings, with vast experience litigating Hatch-Waxman Act ANDA infringement actions. Mr. Goldberg has extensive first-hand experience applying the doctrine of equivalents in patent litigations involving small molecule and biologic pharmaceutical products. Mr. Goldberg’s neuroscience background and deep understanding of the statutory and regulatory framework of the Hatch-Waxman Act provides him invaluable insight in litigating cases to achieve successful outcomes for his clients.

  • Author:

    Brian O'Moore

    Honourable Judge
    Irish High Court

    Brian O'Moore

    Honourable Judge
    Irish High Court
  • Author:

    Cecile Goy

    Partner
    Aramis Law

    Cécile Goy is a member of the Paris Bar focusing on international patent litigation, in particular in the life sciences sector. Before joining Aramis, Cécile worked with an international IP boutique and in-house in the legal department of a car manufacturer. Cécile has also completed an internship at the IP section of the Paris Court of Appeal. Cécile is the author of several articles, including on medical devices and digital therapeutics.

    Cecile Goy

    Partner
    Aramis Law

    Cécile Goy is a member of the Paris Bar focusing on international patent litigation, in particular in the life sciences sector. Before joining Aramis, Cécile worked with an international IP boutique and in-house in the legal department of a car manufacturer. Cécile has also completed an internship at the IP section of the Paris Court of Appeal. Cécile is the author of several articles, including on medical devices and digital therapeutics.

  • Author:

    Charles Collins-Chase

    Partner
    Finnegan

    Charles Collins-Chase focuses on district court patent litigation and appeals before the U.S. Court of Appeals for the Federal Circuit, where he served as a clerk. He uses his chemical engineering background to help clients protect innovations in pharmaceuticals and biotechnology, energy and renewables, and chemical products. He has assisted numerous clients in Hatch-Waxman (ANDA) litigation. Charles has handled district court litigations at every stage, from pre-litigation through discovery, dispositive motions, and trial. He particularly enjoys writing briefs and motions.

     

    Charles has extensive experience at the Federal Circuit, where he has argued cases and assisted clients in over two dozen appeals from district courts and the Patent Trial and Appeal Board (PTAB). He has particular experience in appeals involving patent eligibility under 35 U.S.C. § 101. Charles lectures on and has published in several legal and industry media outlets on strategic IP considerations for protecting AI innovations in the pharmaceutical industry.

     

    Before law school, Charles completed an M.Phil. in engineering for sustainable development at the University of Cambridge, where he researched the feasibility of community-scale biodiesel production using a novel reactor system. His undergraduate thesis research involved synthesizing and characterizing thermosetting polymers made from soybean oil and other renewable resources.

     

    Charles also devotes substantial time to pro bono matters and leads the firm’s pro bono committee. He argues before the Federal Circuit on behalf of veterans seeking service-connected disability benefits. He successfully represented a client seeking Social Security disability benefits, writing the briefs and arguing at a hearing before an administrative law judge.

     

    He holds a J.D. (cum laude) from University of Pennsylvania Law School.

    Charles Collins-Chase

    Partner
    Finnegan

    Charles Collins-Chase focuses on district court patent litigation and appeals before the U.S. Court of Appeals for the Federal Circuit, where he served as a clerk. He uses his chemical engineering background to help clients protect innovations in pharmaceuticals and biotechnology, energy and renewables, and chemical products. He has assisted numerous clients in Hatch-Waxman (ANDA) litigation. Charles has handled district court litigations at every stage, from pre-litigation through discovery, dispositive motions, and trial. He particularly enjoys writing briefs and motions.

     

    Charles has extensive experience at the Federal Circuit, where he has argued cases and assisted clients in over two dozen appeals from district courts and the Patent Trial and Appeal Board (PTAB). He has particular experience in appeals involving patent eligibility under 35 U.S.C. § 101. Charles lectures on and has published in several legal and industry media outlets on strategic IP considerations for protecting AI innovations in the pharmaceutical industry.

     

    Before law school, Charles completed an M.Phil. in engineering for sustainable development at the University of Cambridge, where he researched the feasibility of community-scale biodiesel production using a novel reactor system. His undergraduate thesis research involved synthesizing and characterizing thermosetting polymers made from soybean oil and other renewable resources.

     

    Charles also devotes substantial time to pro bono matters and leads the firm’s pro bono committee. He argues before the Federal Circuit on behalf of veterans seeking service-connected disability benefits. He successfully represented a client seeking Social Security disability benefits, writing the briefs and arguing at a hearing before an administrative law judge.

     

    He holds a J.D. (cum laude) from University of Pennsylvania Law School.

  • Author:

    Chris Buntel

    Co-Founder & CIPO
    Tangibly

    Chris Buntel is a US intellectual property attorney with over 20 years experience connecting innovation and intellectual property law. He is a co-founder and the CIPO of Tangibly.  Chris is passionate about trade secrets – the “next big thing” in intellectual property evolution. While other forms of intellectual property have been well supported for years, people are just now realizing the huge need for trade secret management tools and education.  He has a Ph.D. in Organic Chemistry from Stanford University, and J.D. in Law from University of Houston.

    Chris Buntel

    Co-Founder & CIPO
    Tangibly

    Chris Buntel is a US intellectual property attorney with over 20 years experience connecting innovation and intellectual property law. He is a co-founder and the CIPO of Tangibly.  Chris is passionate about trade secrets – the “next big thing” in intellectual property evolution. While other forms of intellectual property have been well supported for years, people are just now realizing the huge need for trade secret management tools and education.  He has a Ph.D. in Organic Chemistry from Stanford University, and J.D. in Law from University of Houston.

  • Author:

    Christine Kanz

    Partner
    Hoyng Rokh Monegier

    Christine Kanz

    Partner
    Hoyng Rokh Monegier
  • Author:

    Christopher Freeth

    Principal Associate
    Gowling WLG

    Christopher Freeth

    Principal Associate
    Gowling WLG
  • Author:

    Clemens Heusch

    Head of Global Disputes and Resolution
    Nokia

    Clemens Heusch

    Head of Global Disputes and Resolution
    Nokia
  • Author:

    Conrad Eckhardt

    Vice President IP
    Biotronik

    Conrad practices in the IP field for more than 20 years and gained experience across various industries. Having started with Consumer Products at Procter & Gamble he moved on to Pharmaceuticals at Boehringer Ingelheim and is now active in the medical device field, first as Chief IP Counsel at Leica Biosystems and currently as Chief IP Counsel at Biotronik. Conrad is a European Patent Attorney and a European Patent Litigator and has patent litigation experience in Germany, the USA and China.

    Conrad Eckhardt

    Vice President IP
    Biotronik

    Conrad practices in the IP field for more than 20 years and gained experience across various industries. Having started with Consumer Products at Procter & Gamble he moved on to Pharmaceuticals at Boehringer Ingelheim and is now active in the medical device field, first as Chief IP Counsel at Leica Biosystems and currently as Chief IP Counsel at Biotronik. Conrad is a European Patent Attorney and a European Patent Litigator and has patent litigation experience in Germany, the USA and China.